Systemic Adjuvant Chemotherapy for Soft Tissue Sarcomas of the Extremities
- 1 October 1993
- journal article
- Published by Elsevier in Surgical Oncology Clinics of North America
- Vol. 2 (4) , 621-637
- https://doi.org/10.1016/s1055-3207(18)30553-2
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- DNA content prognostic in soft tissue sarcoma: 102 patients followed for 1–10 yearsActa Orthopaedica, 1991
- Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience.Journal of Clinical Oncology, 1990
- Histopathology peer review of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience.Journal of Clinical Oncology, 1989
- Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group.Journal of Clinical Oncology, 1989
- Doxorubicin: Effect of different schedules on toxicity and anti-tumor efficacyEuropean Journal of Cancer and Clinical Oncology, 1989
- Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.Journal of Clinical Oncology, 1989
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).Journal of Clinical Oncology, 1987
- Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomasEuropean Journal of Cancer and Clinical Oncology, 1987
- Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: lack of apparent difference between treatment groups.Journal of Clinical Oncology, 1984